Top Research Highlights

Every day, JDRF leverages the expertise and innovation of distinguished researchers from across the globe to support research for life-changing treatments and ultimately a cure for type 1 diabetes (T1D). Our aim is to progressively reduce the burden of the disease on people’s lives until we can achieve a world without T1D. Please enjoy reading […]

JDRF @ ADA 73rd Scientific Sessions: Sunday Summary

Welcome to our daily summary of  type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions! Each night, we will be posting summaries of notable sessions and presentations.  Below are two relevant sessions from Sunday, June 23: Novel Disease Markers in Type 1 Diabetes For the past several years, JDRF has placed an increasing priority […]

JDRF @ ADA 73rd Scientific Sessions: Saturday Summary

Welcome to our daily summary of type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions!  Each night, we will be posting summaries of notable sessions and presentations.  Below are four relevant sessions from Saturday, June 22: Clinical Trials of T-Cell Therapeutics for Reversing Type 1 Diabetes JDRF continues to place a high priority on […]

JDRF @ ADA 73rd Scientific Sessions: Friday Summary

Welcome to our daily summary of type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions!  Each night, we will be posting summaries of notable sessions and presentations.  Below are two relevant sessions from Friday, June 21.  Beta Cell Failure in Type 1 Diabetes – Cause or Consequences? The fact that T1D is a complicated […]

A Guide to JDRF’s Presence at the American Diabetes Association’s 73rd Scientific Sessions

JDRF-supported research is at the forefront of the American Diabetes Association’s (ADA) 73rd Scientific Sessions this year, June 21-24 in Chicago, with 13 oral presentations, 14 poster presentations, three symposium discussions, one scientific workshop, more than a dozen meetings with research partners, and 20 JDRF staff and senior leadership in attendance to represent scientific progress […]

Testing an Artificial Pancreas System

Living with type 1 diabetes (T1D) requires constant care and attention: blood-glucose monitoring, carbohydrate counting, insulin dosing, and monitoring for high and low blood-glucose levels. But new technology is changing T1D management—and for the good. Just ask Tom Brobson, JDRF’s national director of research investment opportunities, who has doubled as a test subject for JDRF’s […]

Discovery of New Hormone May Impact T1D

The media has come alive, exciting the type 1 diabetes (T1D) community, following the publication of findings of a new hormone in Cell on April 25. The previously unknown hormone, called betatrophin, was found in a mouse study to have the unique ability to promote the natural replication of insulin-producing beta cells. While media reports […]

Workshop Explores Progress of Artificial Pancreas Systems

Leading experts from industry, academia, and government came together in early April in Bethesda, MD, to discuss innovation in the development of an artificial pancreas at a workshop hosted by the National Institutes of Health, the Food and Drug Administration (FDA), and JDRF. Artificial pancreas systems will automate insulin delivery and likely other hormones in […]

JDRF Capitol Chapter Hosts Research Summit

Shared connections to type 1 diabetes (T1D) brought together more than 600 people at the recent JDRF Type 1 Diabetes Research Summit held in Washington, D.C. Hosted by the JDRF Capitol Chapter, this one-day event was filled with informative, easy-to-understand presentations by top T1D researchers. Attendees had the opportunity to hear directly from these top […]